Search results
Author(s):
Tanawan Riangwiwat
,
James C Blankenship
Added:
3 years ago
Author(s):
James C Blankenship
,
Tanawan Riangwiwat
,
Bill D Gogas
Added:
3 years ago
In this practice-focused presentation, Dr Tanawan Riangwiwat (Geisinger Medical Center, Danville, PA, US) talks about radial access, sheath selection and discusses vascular access complications of transradial access for cardiac catheterization that invasive cardiologist and cardiac catheterization team members should be aware of.
After the presentation, Dr Riangwiwat is joined by Dr James C…
View more
Author(s):
Mohamed Abdel-Wahab
Added:
2 years ago
In this short summary interview, Dr Mohamed Abdel-Wahab (Heart Center Leipzig, University of Leipzig, DE) talks about the findings of the CHOICE-CLOSURE trial. The randomized trial investigated the plug-based versus suture-based large-bore vascular closure.
Discussion points:
1. Importance of this study
2. Study design and patient cohort
3. Key findings
4. Impact on practice
5. Next steps
…
View more
Fabrizio D'Abate
Job title: Clinical Vascular Scientist
Author
Philip J Devereaux
Job title: Director of the Division of Cardiology
Author
Author(s):
James R Revenaugh
Added:
3 years ago
This article examines the initial results of the authorÔÇÖs experience to date with percutaneous left ventricular assist (LVA) support of patients in cardiogenic shock, and for temporary left heart support in the setting of high-risk percutaneous intervention. Despite evolving procedural methods, 16 of 18 patients in this study survived to hospital discharge. Intraprocedural complications were…
View more
Ramzi Ajjan
Job title: Professor of Metabolic Medicine and an Honorary Consultant in Diabetes and Endocrinology at Leeds University and Leeds Teaching Hospitals Trust
Author
Author(s):
Stephen Ku
,
Steven V Edelman
Added:
3 years ago
Cardiovascular disease is an important cause of morbidity and mortality in patients with type 1 and especially type 2 diabetes mellitus.1,2 Data from prospective studies suggest that diabetes is associated with a two to fourfold excess risk of coronary heart disease and coronary death.3–5 It was therefore hoped that controlling hyperglycemia would reduce cardiovascular disease incidence and…
View more
Author(s):
Maura Marcucci
Added:
2 years ago
In this short interview from our coverage of the ACC.22 late-breaking trials, Dr Maura Marcucci (McMaster University, ON, CA) discusses a sub-study of the POISE-3 trial, which sought to evaluate the effects of a perioperative hypotension-avoidance strategy, compared to a hypertension-avoidance strategy in patients undergoing non-cardiac surgery (NCT03505723).
Discussion Points:
Study…
View more
Author(s):
Jimmy Kerrigan
,
Timir K Paul
,
Jay Patel
,
et al
Added:
6 months ago